Today: 22 July 2026
Browse Category

Earnings 7 May 2026 - 14 June 2026

Casey’s General Stores Gains as Fuel Margins, Pizza Sales, Buybacks Push Up CASY

Casey’s General Stores Gains as Fuel Margins, Pizza Sales, Buybacks Push Up CASY

• Casey’s shares jumped roughly 15% Wednesday after both profit and revenue topped estimates for the fiscal fourth quarter.• The quarter saw a boost from fuel margins and inside-store sales, especially in prepared foods—both key metrics for investors.• The company also lifted its dividend, expanded its buyback to $1 billion, and gave guidance for more EBITDA growth in fiscal 2027.
10 June 2026
Salesforce Tops Estimates, But Stock Dips as AI Concerns Return

Salesforce Tops Estimates, But Stock Dips as AI Concerns Return

Salesforce shares edged lower late Wednesday. The company put out a second-quarter revenue outlook that missed what Wall Street was looking for, adding to pressure on a stock that’s already been under fire this year over AI concerns in the software sector. The stock last traded down 0.8% at $177.51, after Reuters reported it fell by about 3% after hours.
Sea’s Earnings Rebound Is Real, but the Cost Fight Is Not Over

Sea’s Earnings Rebound Is Real, but the Cost Fight Is Not Over

Sea Limited’s latest results were a jumble, but one thing stood out: demand is outpacing what analysts had penciled in. Shares were quoted at $96.13 in pre-market action just after 7:39 a.m. Eastern, a 13% pop from the $85.07 close. First-quarter revenue hit $7.10 billion, topping the $6.46 billion estimate, while earnings per share landed at $0.67—ten cents shy of the consensus. U.S. markets hadn’t opened yet, but the reason for the surge was clear enough.
12 May 2026
Hims & Hers Health Earnings Today: Why One GLP-1 Question Could Move HIMS Stock

Hims & Hers Health Earnings Today: Why One GLP-1 Question Could Move HIMS Stock

Investors eye Hims & Hers Health Inc. as it approaches Monday’s first-quarter results, with attention locked on the future of its weight-loss segment—especially after the company pulled back from widely promoted compounded GLP-1 drugs. Earnings will post after the U.S. markets close, followed by a 5 p.m. ET conference call, according to Hims & Hers.
Go toTop